Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07253311Recruiting
Testing a rapid test for Candida auris
This trial is testing a rapid test to detect Candida auris, a hard-to-treat fungus. You can join if your doctor suspects you have this infection or you're being checked for it on your skin, and your lab sample is grown on specific plates or broths.
AthensAges 18 years+ - NCT07253974Recruiting
Atrial Fibrillation Stroke Recovery Study
This study follows people who had a stroke linked to atrial fibrillation (an irregular heartbeat) and are in a rehabilitation program. Researchers want to see how recovery goes and what helps patients improve.
BarcelonaAges 18–99 - NCT07254013Recruiting
LBBAP Pacemaker Monitoring with Portable ECG
This study is testing a portable heart monitoring device to help doctors check how well a special pacemaker (LBBAP) is working. It may help people who need a new or upgraded pacemaker or heart device.
Besançon, FranceAges 18 years+ - NCT07254091RecruitingEarly Phase 1
Implantable chip to test chemo in pancreatic cancer surgery
This trial tests a tiny implantable device that measures how different chemotherapy drugs work on your tumor during surgery. The goal is to find the most effective treatment for your specific cancer.
New Hyde Park, New YorkAges 18 years+ - NCT07254754RecruitingPhase 2
CAR-T cell therapy for late-relapse aggressive lymphoma
This trial tests a special immune cell therapy (CAR-T cells) for people with a type of aggressive lymphoma that returned more than a year after first treatment. It aims to see if this therapy can help control the cancer again.
A Coruña, A CoruñaAges 18 years+ - NCT07256119Recruiting
Can a supplement help ease radiation skin burns?
This study tests whether taking an antioxidant called alpha lipoic acid can reduce skin irritation caused by radiation therapy in women with early-stage breast cancer. If you qualify, you would receive the supplement during your radiation treatment to see if it helps protect your skin.
ZagazigAges 18–75 - NCT07256522Recruiting
Comparing treatments for trigger finger
This study compares three non-surgical treatments for a single trigger finger: a splint, paraffin wax, and a type of mud therapy. It aims to find which works best for improving finger movement and reducing pain.
Konya, KonyaAges 18–75 - NCT07258160RecruitingPhase 2
Cordycepin for low CD8+ cells in solid tumor patients
This trial tests a supplement derived from cordyceps mushrooms to see if it can raise low CD8+ immune cell levels in people who have had solid tumors. It may help strengthen your immune system after previous cancer treatments.
Suzhou, JiangsuAges 18 years+ - NCT07258407RecruitingPhase 1/Phase 2
TD001 for men with PSMA-positive metastatic prostate cancer
This trial tests a new drug, TD001, in men whose prostate cancer has spread and is no longer responding to standard hormone therapy. It aims to see if TD001 is safe and effective against tumors that show a specific marker called PSMA.
New Haven, ConnecticutAges 18 years+ - NCT07260344Recruiting
Testing two new ways to find early mouth precancer
This study compares two non-invasive methods to detect precancerous sores in the mouth. It aims to find a simpler way to catch early changes before they become cancer.
Taipei, TaipeiAges 30–80 - NCT07260695RecruitingPhase 4
Odyssey Lens Study for Post-LASIK Cataract Patients
This trial tests a new type of lens implant (Odyssey IOL) for people who have had LASIK surgery and now have cataracts. It aims to see how well the lens works after cataract surgery in both eyes.
Venice, FloridaAges 50 years+ - NCT07261644RecruitingPhase 3
Study of a new drug for active ankylosing spondylitis
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07261891Recruiting
Lab study of JAK-STAT related disorders
This study looks at blood or tissue samples from people with certain genetic disorders that affect a key cell communication pathway (JAK-STAT). The goal is to learn more about these disorders and test potential treatments in the lab.
Leuven, Vlaams-BrabantAges 18 years+ - NCT07262281RecruitingPhase 1
Safety study of HY6725 in healthy adults
This trial tests a new drug called HY6725 in healthy volunteers to see if it is safe and how the body processes it. It may help pave the way for future treatments.
MelbourneAges 18–55 - NCT07262619RecruitingPhase 1/Phase 2
Study of EIK1005 for advanced solid tumors
This study tests an experimental drug called EIK1005, either alone or combined with another drug (pembrolizumab), for people with advanced solid tumors, especially those with MSI-H or dMMR cancers (tumors that have trouble repairing their DNA). The goal is to see if it can shrink tumors or slow cancer growth.
Morristown, New JerseyAges 18 years+ - NCT07263113Recruiting
Gum disease and heart health study
This study looks at whether severe gum disease (periodontitis) is linked to stiffer arteries and higher heart risk. If you have advanced gum disease or healthy gums, you may be able to join to help researchers understand this connection.
NantesAges 40–69 - NCT07264270RecruitingPhase 1
A new injection for long-term sciatica pain
This trial tests a new medicine called C-1101, given as a shot into the spine, to see if it safely reduces pain from chronic sciatica. It is for people who have not gotten enough relief from standard treatments.
Broadmeadow, New South WalesAges 18–65 - NCT07264439Recruiting
Virtual reality with hypnosis for Alzheimer's patients during hygiene care
This trial tests whether virtual reality headsets showing hypnosis scenes can reduce agitation and resistance during bathing or toileting in people with Alzheimer's disease. It aims to make daily care calmer and less stressful for patients and caregivers.
AmiensAges 18 years+ - NCT07264569RecruitingPhase 1/Phase 2
Testing a new drug for lung cancer that has spread to the brain or spinal fluid
This trial tests a new drug called BioTTT001 for people with non-small cell lung cancer (NSCLC) that has spread to the fluid around the brain or the lining of the brain (leptomeninges). The goal is to see if the drug is safe and can help control the cancer.
Zhengzhou, HenanAges 18–70 - NCT07265284RecruitingPhase 3
IBI112 for teens with moderate to severe plaque psoriasis
This study tests a new medicine called IBI112 for teens aged 12–18 with moderate to severe plaque psoriasis. It aims to see if the medicine is safe and can help clear skin better than placebo.
Beijing, Beijing MunicipalityAges 12–18 - NCT07265570RecruitingPhase 2
ISM5411 for active ulcerative colitis
This trial tests an experimental drug (ISM5411) for people with active ulcerative colitis. The goal is to see if the drug can reduce inflammation and improve symptoms.
Beijing, Beijing MunicipalityAges 18–75 - NCT07267130RecruitingPhase 1
Safety study of TQC3302 inhaler in healthy adults
This trial tests a new inhaled medication (TQC3302) in healthy adults to see if it is safe and how the body processes it. It is a first-in-human study for a potential treatment for lung conditions.
Beijing, Beijing MunicipalityAges 18–55 - NCT07267156Recruiting
New Dressing After Bunion Surgery
This study tests a new type of bandage or dressing used after bunion (hallux valgus) surgery. It aims to see if this dressing works better than the usual dressing to help your foot heal.
Geneva, Canton of GenevaAges 18 years+ - NCT07267260RecruitingPhase 2
Vonoprazan to prevent ulcers after variceal banding
This trial tests whether vonoprazan can reduce ulcers caused by a procedure that ties off enlarged veins in the esophagus (variceal band ligation). It is meant for people with liver cirrhosis who are scheduled to receive this treatment.
Lahore, Punjab ProvinceAges 18–75
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.